X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (309) 309
Publication (34) 34
Conference Proceeding (12) 12
Book / eBook (8) 8
Book Chapter (8) 8
Book Review (2) 2
Data Set (1) 1
Government Document (1) 1
Newspaper Article (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (157) 157
index medicus (151) 151
bipolar disorder (118) 118
male (96) 96
female (87) 87
adult (83) 83
psychiatry (82) 82
bi 1356 (61) 61
middle aged (61) 61
linagliptin (56) 56
pharmacology & pharmacy (56) 56
neurosciences (55) 55
schizophrenia (50) 50
animals (44) 44
pharmacokinetics (40) 40
mental disorders (37) 37
young adult (36) 36
analysis (35) 35
diabetes mellitus, type 2 - drug therapy (35) 35
pharmacodynamics (34) 34
adolescent (33) 33
dipeptidyl peptidase-4 inhibitor (32) 32
dpp-4 inhibitor (32) 32
type 2 diabetes (32) 32
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (31) 31
aged (29) 29
purines - pharmacokinetics (27) 27
quinazolines - pharmacokinetics (27) 27
double-blind (26) 26
dipeptidyl-peptidase iv inhibitors - pharmacology (23) 23
purines - pharmacology (23) 23
quinazolines - pharmacology (23) 23
research (23) 23
depression (22) 22
dipeptidyl-peptidase iv inhibitors - therapeutic use (22) 22
dose-response relationship, drug (22) 22
medicine & public health (21) 21
purines - therapeutic use (21) 21
quinazolines - therapeutic use (21) 21
risk factors (19) 19
tolerability (19) 19
major depressive disorder (18) 18
rats (18) 18
saturable binding (18) 18
drug therapy (17) 17
hypoglycemic agents - therapeutic use (17) 17
purines - adverse effects (17) 17
quinazolines - adverse effects (17) 17
article (16) 16
bipolar disorder - drug therapy (16) 16
clinical neurology (16) 16
clinical trials (16) 16
hypoglycemic agents - pharmacokinetics (16) 16
lithium (16) 16
aged, 80 and over (15) 15
brain (15) 15
care and treatment (15) 15
case-control studies (15) 15
magnetic resonance imaging (15) 15
purines - administration & dosage (15) 15
quinazolines - administration & dosage (15) 15
studies (15) 15
diabetes (14) 14
dipeptidyl-peptidase iv inhibitors - administration & dosage (14) 14
dipeptidyl-peptidase iv inhibitors - adverse effects (14) 14
drug interactions (14) 14
glycemic control (14) 14
internal medicine (14) 14
medical research (14) 14
metformin (14) 14
psychology (14) 14
treatment outcome (14) 14
engineering, electrical & electronic (13) 13
genotype (13) 13
glucagon-like peptide-1 (13) 13
pharmacology/toxicology (13) 13
safety (13) 13
biochemistry & molecular biology (12) 12
bipolar (12) 12
cell biology (12) 12
child (12) 12
endocrinology & metabolism (12) 12
glucose (12) 12
health aspects (12) 12
mental depression (12) 12
metaanalysis (12) 12
mice (12) 12
patients (12) 12
prefrontal cortex (12) 12
schizophrenia - genetics (12) 12
type-2 diabetes-mellitus (12) 12
behavior (11) 11
double-blind method (11) 11
genetic aspects (11) 11
hypoglycemic agents - pharmacology (11) 11
metabolism (11) 11
neurology (11) 11
pharmacology (11) 11
psychosis (11) 11
risk (11) 11
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
OISE - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JOURNAL OF PHARMACY AND PHARMACOLOGY, ISSN 0022-3573, 01/2009, Volume 61, Issue 1, pp. 55 - 62
Objectives The purpose of this study was to characterise the plasma protein binding of BI 1356. Methods BI 1356 (proposed trade name ONDERO) is a novel... 
MEMBRANE | dipeptidyl peptidase-4 inhibitor | plasma protein binding | CANCER | IV CD26 | LACKING | type 2 diabetes | ENZYME | BI-1356 | pharmacokinetics | DEGRADATION | PHARMACOLOGY & PHARMACY | BI 1356 | STRAIN
Journal Article
Journal Article
Journal Article
DIABETIC MEDICINE, ISSN 0742-3071, 11/2011, Volume 28, Issue 11, pp. 1352 - 1361
Aims To examine the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in persons with Type 2 diabetes mellitus inadequately controlled... 
Type 2 diabetes | GLYCEMIC CONTROL | linagliptin | sulphonylurea | DIPEPTIDYL-PEPTIDASE-4 INHIBITOR | CONSENSUS | dipeptidyl peptidase-4 inhibitor | metformin | PHARMACODYNAMICS | MELLITUS | BETA-CELL FUNCTION | ADD-ON THERAPY | PHARMACOKINETICS | ENDOCRINOLOGY & METABOLISM | BI 1356 | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Purines - administration & dosage | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Linagliptin | Purines - adverse effects | Purines - therapeutic use | Sulfonylurea Compounds - administration & dosage | Metformin - administration & dosage | Drug Therapy, Combination | Body Mass Index | Hypoglycemic Agents - therapeutic use | Fasting | Double-Blind Method | Treatment Outcome | Biomarkers - blood | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Diabetes Mellitus, Type 2 - blood | Quinazolines - therapeutic use | Adolescent | Quinazolines - adverse effects | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Analysis | Hypoglycemic agents | Glucose | Diabetes | Research | Dextrose | Diabetes therapy
Journal Article
Journal of Chromatographic Science, ISSN 0021-9665, 10/2016, Volume 54, Issue 9, pp. 1573 - 1577
A sensitive and reproducible HPLC method for the determination of linagliptin (LNG) in rat plasma was developed and validated using pindolol (PIN) as the... 
TARGET | CHEMISTRY, ANALYTICAL | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | TOLERABILITY | SATURABLE BINDING | BIOCHEMICAL RESEARCH METHODS | DPP-4 INHIBITOR | BI 1356
Journal Article